Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Theranostics ; 10(26): 12011-12025, 2020.
Article in English | MEDLINE | ID: mdl-33204326

ABSTRACT

Calcium oxalate (CaOx) crystal can trigger kidney injury, which contributes to the pathogenesis of nephrocalcinosis. The phenotypes of infiltrating macrophage may impact CaOx-mediated kidney inflammatory injury as well as crystal deposition. How aryl hydrocarbon receptor (AhR) regulates inflammation and macrophage polarization is well understood; however, how it modulates CaOx nephrocalcinosis remains unclear. Methods: Mice were intraperitoneally injected with glyoxylate to establish CaOx nephrocalcinosis model with or without the treatment of AhR activator 6-formylindolo(3,2-b)carbazole (FICZ). Positron emission tomography computed tomography (PET-CT) imaging, Periodic acid-Schiff (PAS) staining, and polarized light optical microscopy were used to evaluate kidney injury and crystal deposition in mice kidney. Western blotting, immunofluorescence, chromatin immunoprecipitation, microRNA-fluorescence in situ hybridization, and luciferase reporter assays were applied to analyze polarization state and regulation mechanism of macrophage. Results: AhR expression was significantly upregulated and negatively correlated with interferon-regulatory factor 1 (IRF1) and hypoxia inducible factor 1-alpha (HIF-1α) levels in a murine CaOx nephrocalcinosis model following administration of FICZ. Moreover, AhR activation suppressed IRF1 and HIF-1α levels and decreased M1 macrophage polarization in vitro. In terms of the mechanism, bioinformatics analysis and chromatin immunoprecipitation assay confirmed that AhR could bind to miR-142a promoter to transcriptionally activate miR-142a. In addition, luciferase reporter assays validated that miR-142a inhibited IRF1 and HIF-1α expression by directly targeting their 3'-untranslated regions. Conclusions: Our results indicated that AhR activation could diminish M1 macrophage polarization and promote M2 macrophage polarization to suppress CaOx nephrocalcinosis via the AhR-miR-142a-IRF1/HIF-1α pathway.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Calcium Oxalate/metabolism , Macrophages/immunology , MicroRNAs/genetics , Nephrocalcinosis/immunology , Receptors, Aryl Hydrocarbon/metabolism , 3' Untranslated Regions/genetics , Animals , Basic Helix-Loop-Helix Transcription Factors/agonists , Basic Helix-Loop-Helix Transcription Factors/analysis , Carbazoles/administration & dosage , Case-Control Studies , Cells, Cultured , Computational Biology , Disease Models, Animal , Epithelial Cells , Glyoxylates/administration & dosage , Glyoxylates/toxicity , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Interferon Regulatory Factor-1/genetics , Kidney/diagnostic imaging , Kidney/drug effects , Kidney/pathology , Kidney/surgery , Macrophage Activation , Macrophages/metabolism , Male , Mice , MicroRNAs/metabolism , Nephrocalcinosis/chemically induced , Nephrocalcinosis/diagnosis , Nephrocalcinosis/surgery , Nephrolithotomy, Percutaneous , Positron Emission Tomography Computed Tomography , Primary Cell Culture , Receptors, Aryl Hydrocarbon/agonists , Receptors, Aryl Hydrocarbon/analysis , Transcriptional Activation/immunology , Up-Regulation/immunology
2.
J Pediatr Urol ; 13(4): 355.e1-355.e6, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28729176

ABSTRACT

INTRODUCTION: Renal stone disease diagnosed in the first year of life is relatively uncommon. While risk factors such as low birth weight, furosemide exposure, and metabolic disorders are well established, there exists little information regarding resolution rates and need for surgical intervention. Our study objective was to evaluate urolithiasis and renal calcification resolution rates, time to resolution, and need for surgical intervention in children diagnosed in their first year of life. MATERIAL AND METHODS: REB approved retrospective chart review of children younger than 12 months of age (corrected for prematurity) diagnosed with nephrolithiasis and/or nephrocalcinosis in a tertiary pediatric hospital between April 2000 and August 2015 with a minimum 1-year follow-up period. Exact logistic regression was performed to assess the relationship between size of the largest stone (on either side) and the need for surgical intervention. Kaplan-Meier curves were constructed to examine time to stone resolution among those not requiring surgical intervention. RESULTS: 62 patients (61% male) were diagnosed with stones or nephrocalcinosis by ultrasound at a median age of 2.9 months. Of these, 37% had been admitted to the NICU because of prematurity, low birth weight or comorbidities. A total of 45 patients were found to have stones (Table); 35 of these had a stone at initial ultrasound and 10 initially diagnosed as nephrocalcinosis were later confirmed to have a stone. 67% of all stones were asymptomatic on presentation. Metabolic anomalies were present in 56% (35/62), and 16% (10/62) required medical treatment. Seven patients ultimately required surgical intervention. Stone size was found to predict the eventual need for surgical intervention (OR 3.52, 95% CI 1.47-12.78) for each 0.1 mm increase in diameter). Among patients not requiring surgical intervention (n = 38), the estimated median time to spontaneous resolution of urolithiasis was 1.1 years (95% CI 0.89-1.53, range 2 months-6 years) and 1.2 years for nephrocalcinosis (95% CI 0.59-2.13). CONCLUSIONS: Spontaneous resolution was a common outcome for newborns and infants diagnosed with urolithiasis in the first year of life, but high variability in time-to-resolution was observed. Only a small proportion who had confirmed stones on ultrasound required surgical intervention (15%), and large stone size was a predictive factor for surgery.


Subject(s)
Nephrocalcinosis/diagnosis , Nephrocalcinosis/surgery , Nephrolithiasis/diagnosis , Nephrolithiasis/surgery , Female , Humans , Infant , Male , Patient Selection , Retrospective Studies , Treatment Outcome , Ultrasonography
3.
Clin Nephrol ; 85(6): 346-52, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27007868

ABSTRACT

BACKGROUND: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare, autosomal recessive condition caused by mutations in CLDN16 or CLDN19, which encode for tight junction proteins, claudin-16 and claudin-19, respectively. This condition often has a delayed diagnosis in patients with no prior family history due to a lack of specific clinical symptoms. Description of case, diagnosis, and treatment: A 4-year, 10-month-old Caucasian boy presented with failure to thrive, developmental delay, and ocular findings consisting of horizontal nystagmus, bilateral macular staphylomas, and high myopia. Laboratory studies revealed hypercalciuria, hypomagnesemia, and renal insufficiency. Renal ultrasound showed bilateral small kidneys with medullary nephrocalcinosis. Candidate gene sequencing performed at age 7 years identified a novel, homozygous, frameshift mutation c.140_141delAT (p.Tyr47Stop) within CLDN19, confirming the molecular diagnosis of FHHNC. Due to rapid renal progression, the proband underwent renal transplant at age 10 years, 10 months. FHHNC was prenatally diagnosed in the proband's sister, who was found at birth to have ocular findings and hypomagnesemia. In addition, she had feeding intolerance and persistent hypoglycemia with hyperinsulinism that has required chronic diazoxide therapy. CONCLUSIONS: Although rare, FHHNC should be suspected in patients who present with nephrocalcinosis in the setting of congenital eye anomalies..


Subject(s)
Claudins/genetics , Hypercalciuria/diagnosis , Hypercalciuria/genetics , Nephrocalcinosis/diagnosis , Nephrocalcinosis/genetics , Renal Tubular Transport, Inborn Errors/diagnosis , Renal Tubular Transport, Inborn Errors/genetics , Child , Child, Preschool , Female , Frameshift Mutation , Homozygote , Humans , Hypercalciuria/surgery , Infant, Newborn , Kidney Transplantation , Male , Nephrocalcinosis/surgery , Prenatal Diagnosis , Renal Tubular Transport, Inborn Errors/surgery , Siblings
4.
Transplantation ; 100(6): 1318-21, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26760567

ABSTRACT

BACKGROUND: Congenital hypoparathyroidism can be severely debilitating for patients, leading to renal failure at young age. Parathyroid transplantation may represent a permanent parathyroid replacement therapy. In patients already on immunosuppression for other organ transplant, there is little additional risk involved with parathyroid allotransplantation. METHODS: Robotic assisted transaxillary single parathyroidectomy is performed on a living donor also donating a kidney to her sibling. RESULTS: Recipient total serum PTH levels became detectable after 3 days from the procedure and maintained for 9 months after transplant with minimal calcium supplementation after the procedure. Literature review and previous results are summarized. CONCLUSIONS: Obtaining a parathyroid gland and a kidney from the same donor reduces the exposure to different HLA antigens. The combined procedure using minimally invasive surgery is safe, with the additional cosmetic advantage and convenience for the willing donor. In the setting of need for immunosuppression, additional transplantation to treat the cause is safe and justified in the recipients.


Subject(s)
Kidney Transplantation/methods , Living Donors , Nephrocalcinosis/surgery , Parathyroid Glands/surgery , Parathyroid Glands/transplantation , Parathyroidectomy/methods , Adult , Calcium/therapeutic use , Female , HLA Antigens/chemistry , Humans , Immunosuppression Therapy , Immunosuppressive Agents/therapeutic use , Kidney/pathology , Parathyroid Hormone/blood , Renal Insufficiency/surgery , Robotic Surgical Procedures , Siblings , Transplantation, Homologous , Young Adult
5.
J Urol ; 194(5): 1308-12, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25988516

ABSTRACT

PURPOSE: Nephrocalcinosis is commonly present in primary hyperparathyroidism, distal renal tubular acidosis and medullary sponge kidney disease. To our knowledge it has not been studied in patients with calcium phosphate stones who do not have systemic disease. MATERIALS AND METHODS: We studied patients undergoing percutaneous nephrolithotomy who had calcium phosphate or calcium oxalate stones and did not have hyperparathyroidism, distal renal tubular acidosis or medullary sponge kidney disease. On postoperative day 1 all patients underwent noncontrast computerized tomography. If there were no residual calcifications, the patient was categorized as not having nephrocalcinosis. If there were residual calcifications, the patient underwent secondary percutaneous nephrolithotomy. If the calcifications were found to be stones, the patient was categorized as not having nephrocalcinosis. If the calcifications were not stones, the patient was categorized as having nephrocalcinosis. Patients were grouped based on the type of stones that formed, including hydroxyapatite, brushite and idiopathic calcium oxalate. The extent of nephrocalcinosis was quantified as 0--absent nephrocalcinosis to 3--extensive nephrocalcinosis. Patients with residual calcifications on postoperative day 1 noncontrast computerized tomography who did not undergo secondary percutaneous nephrolithotomy were excluded from analysis. The presence or absence of nephrocalcinosis was correlated with metabolic studies. RESULTS: A total of 67 patients were studied, including 14 with hydroxyapatite, 19 with brushite and 34 with idiopathic calcium oxalate calculi. Nephrocalcinosis was present in 10 of 14 (71.4%), 11 of 19 (57.9%) and 6 of 34 patients (17.6%) in the hydroxyapatite, brushite and idiopathic calcium oxalate groups, respectively (chi-square p = 0.01). The mean extent of nephrocalcinosis per group was 1.98, 1.32 and 0.18 for hydroxyapatite, brushite and idiopathic calcium oxalate, respectively (p ≤0.001). The presence of nephrocalcinosis positively correlated with urine calcium excretion (mean ± SD 287.39 ± 112.49 vs 223.68 ± 100.67 mg per day, p = 0.03). CONCLUSIONS: Patients without systemic disease who form hydroxyapatite and brushite stones commonly have coexistent nephrocalcinosis. Nephrocalcinosis can occur in calcium oxalate stone formers but the quantity and frequency of nephrocalcinosis in this group are dramatically less.


Subject(s)
Calcium Oxalate/metabolism , Calcium Phosphates/metabolism , Kidney Calculi/metabolism , Nephrocalcinosis/metabolism , Nephrostomy, Percutaneous , Tomography, X-Ray Computed , Humans , Kidney Calculi/diagnostic imaging , Kidney Calculi/surgery , Nephrocalcinosis/diagnostic imaging , Nephrocalcinosis/surgery , Risk Factors
6.
J Clin Endocrinol Metab ; 99(8): 2646-50, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24758187

ABSTRACT

CONTENT: Management of primary hyperparathyroidism has evolved over the past two decades, yet impaired renal function has consistently been a surgical indication. This recommendation has been based upon the historical association between primary hyperparathyroidism and renal impairment, and a review of the literature is needed to determine whether such a recommendation is warranted. EVIDENCE ACQUISITION AND SYNTHESIS: PubMed was utilized to identify English-language articles published between January 1990 and February 2014 using keywords related to hyperparathyroidism and renal function. The keywords were "primary hyperparathyroidism," "surgery," "parathyroidectomy," "kidney," "renal," "glomerular filtration rate," and "creatinine." Of the 1926 articles obtained with this search, all articles germane to the topic that quantified the relationship between primary hyperparathyroidism and renal function were included. All references within these articles were investigated for inclusion. When helpful, data tables were constructed to summarize the results succinctly. CONCLUSIONS: A secondary elevation of PTH levels has not been consistently shown to occur at the threshold currently indicated for surgical intervention. While renal impairment is seen with more significant disease, mild asymptomatic primary hyperparathyroidism has not been conclusively associated with renal impairment. Furthermore, there is no evidence to suggest that surgically curing primary hyperparathyroidism via a parathyroidectomy has any impact upon renal function.


Subject(s)
Hyperparathyroidism, Primary/complications , Hyperparathyroidism, Primary/surgery , Parathyroidectomy/statistics & numerical data , Renal Insufficiency/etiology , Renal Insufficiency/surgery , Disease Progression , Humans , Hyperparathyroidism, Primary/diagnosis , Hyperparathyroidism, Primary/epidemiology , Nephrocalcinosis/epidemiology , Nephrocalcinosis/etiology , Nephrocalcinosis/surgery , Nephrolithiasis/epidemiology , Nephrolithiasis/etiology , Nephrolithiasis/surgery , Parathyroidectomy/standards , Practice Guidelines as Topic/standards , Prognosis , Renal Insufficiency/epidemiology
8.
Pediatr Nephrol ; 25(11): 2359-62, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20628764

ABSTRACT

Primary hyperoxaluria type 1 (PH-1) is a rare autosomal recessive disease caused by the absence or deficiency of the liver-specific intermediary metabolic enzyme alanine glyoxylate aminotransferase. The prognosis of this metabolic disease is poor. Theoretically, the primary metabolic defect can be cured by liver transplantation. However, controversy exists around the age and stage of the disease that liver transplantation should be performed. We report on a patient who presented at the early age of 2 months with nephrocalcinosis. Isolated liver transplantation was performed at the age of 21 months. Eight years later, the estimated glomerular filtration rate was 85 ml/min/1.73 m(2), and imaging studies did not reveal nephrocalcinosis. This case report supports the strategy of early isolated liver transplantation in patients with PH-1.


Subject(s)
Hyperoxaluria, Primary/surgery , Liver Transplantation/methods , Nephrocalcinosis/complications , Child , Consanguinity , Follow-Up Studies , Glomerular Filtration Rate , Humans , Hyperoxaluria, Primary/complications , Hyperoxaluria, Primary/metabolism , Infant , Liver Transplantation/adverse effects , Male , Nephrocalcinosis/surgery , Prognosis , Treatment Outcome
9.
BMC Nephrol ; 9: 12, 2008 Sep 24.
Article in English | MEDLINE | ID: mdl-18816383

ABSTRACT

BACKGROUND: Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive disorder of renal calcium and magnesium wasting frequently complicated by progressive chronic renal failure in childhood or adolescence. METHODS: A 7 year old boy was investigated following the findings of marked renal insufficiency and nephrocalcinosis in his 18-month old sister. He too was found to have extensive nephrocalcinosis with increased fractional excretion of magnesium: 12.4% (<4%) and hypercalciuria: 5.7 mmol (< 2.5/24 hours). He had renal impairment, partial distal renal tubular acidosis and defective urinary concentrating ability. Therapy with thiazide diuretics and magnesium supplements failed to halt the progression of the disorder. Both children subsequently underwent renal transplantation. Both children's parents are unaffected and there is one unaffected sibling. RESULTS: Mutation analysis revealed 2 heterozygous mutations in the claudin 16 gene (CLDN16) in both affected siblings; one missense mutation in exon 4: C646T which results in an amino acid change Arg216Cys in the second extracellular loop of CLDN16 and loss of function of the protein and a donor splice site mutation which changes intron 4 consensus splice site from 'GT' to 'TT' resulting in decreased splice efficiency and the formation of a truncated protein with loss of 64 amino acids in the second extracellular loop. CONCLUSION: The mutations in CLDN16 in this kindred affect the second extra-cellular loop of claudin 16. The clinical course and molecular findings suggest complete loss of function of the protein in the 2 affected cases and highlight the case for molecular diagnosis in individuals with FHHNC.


Subject(s)
Genetic Carrier Screening , Hypercalciuria/genetics , Membrane Proteins/genetics , Mutation/genetics , Nephrocalcinosis/genetics , Adult , Claudins , Extracellular Space/genetics , Female , Gitelman Syndrome/diagnosis , Gitelman Syndrome/genetics , Gitelman Syndrome/surgery , Humans , Hypercalciuria/diagnosis , Hypercalciuria/surgery , Kidney Transplantation , Male , Membrane Proteins/deficiency , Nephrocalcinosis/diagnosis , Nephrocalcinosis/surgery , RNA Splicing/genetics
10.
Dermatol Online J ; 10(1): 10, 2004 Jul 15.
Article in English | MEDLINE | ID: mdl-15347492

ABSTRACT

A 30-year-old woman with primary hyperoxaluria type I (PHI) developed livedo reticularis with overlying ulcerations on her legs 16 months after receiving a liver-kidney transplant. A skin biopsy of the lesion showed deposits of calcium oxalate. To our knowledge, there have been no reported cases of livedo reticularis in patients with PH1 after a combined liver-kidney transplant.


Subject(s)
Hyperoxaluria, Primary/complications , Kidney Transplantation , Leg Ulcer/etiology , Liver Transplantation , Postoperative Complications/etiology , Skin Diseases, Vascular/etiology , Adult , Calcium Oxalate/analysis , Debridement , Disease Progression , Fatal Outcome , Female , Heart Diseases/etiology , Humans , Hyperoxaluria, Primary/surgery , Leg Ulcer/surgery , Nephrocalcinosis/etiology , Nephrocalcinosis/surgery , Plasmapheresis , Raynaud Disease/etiology , Recurrence , Skin/chemistry , Skin Transplantation , Transplantation, Autologous , Transplantation, Heterologous
11.
Pediatr Nephrol ; 17(11): 896-8, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12432429

ABSTRACT

Primary hyperoxaluria type I is an autosomal recessive metabolic disease in which excessive oxalates are formed by the liver and excreted by the kidneys, causing a wide spectrum of disease, ranging from renal failure in infancy to mere renal stones in late adulthood. The diagnosis may be suspected when clinical signs and increased urinary oxalate and glycolate excretion present, and is confirmed by the measurement of decreased alanine:glyoxylate aminotransferase activity in a liver sample. The enzymatic assay is not readily available to pediatric nephrologists in many parts of the world. We describe three families from Croatia in whom the diagnosis of primary hyperoxaluria was solely based on clinical findings that included nephrolithiasis and nephrocalcinosis accompanied by increased urinary oxalates and glycolate excretion, as enzymatic assays of liver samples could not be performed. Mutation analysis of the AGXT gene encoding the defective enzyme confirmed the diagnosis, revealing three alleles carrying the C156ins mutation and two the G630A mutation. Screening first-degree relatives for the relevant mutation disclosed an asymptomatic affected sibling. Mutation analysis of the AGXT gene is a non-invasive and accurate tool for the diagnosis of type I primary hyperoxaluria that may replace enzymatic assays of liver biopsies.


Subject(s)
DNA Mutational Analysis , Hyperoxaluria, Primary/diagnosis , Hyperoxaluria, Primary/genetics , Adult , Age of Onset , Albania , Alleles , Child, Preschool , Croatia , Female , Humans , Hyperoxaluria, Primary/surgery , Kidney Calculi/etiology , Kidney Calculi/genetics , Kidney Calculi/surgery , Kidney Failure, Chronic/etiology , Kidney Failure, Chronic/genetics , Kidney Failure, Chronic/surgery , Kidney Transplantation , Male , Nephrocalcinosis/diagnosis , Nephrocalcinosis/genetics , Nephrocalcinosis/surgery , Pedigree
12.
Urology ; 57(3): 554, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11248642

ABSTRACT

Nephrolithiasis secondary to primary hyperparathyroidism infrequently complicates pregnancy. It can cause severe maternal and fetal complications. We present a case of a pregnant woman with nephrolithiasis and primary hyperparathyroidism. We reviewed the management of nephrolithiasis due to primary hyperparathyroidism during pregnancy. We believe that early recognition and timely intervention can significantly reduce the incidence of complications.


Subject(s)
Hyperparathyroidism/complications , Nephrocalcinosis/etiology , Pregnancy Complications , Adult , Female , Humans , Hyperparathyroidism/blood , Hyperparathyroidism/surgery , Nephrocalcinosis/blood , Nephrocalcinosis/surgery , Nephrostomy, Percutaneous , Parathyroidectomy , Pregnancy , Pregnancy Complications/blood , Pregnancy Complications/etiology , Pregnancy Complications/surgery , Reoperation , Thyroidectomy , Ureteral Obstruction/blood , Ureteral Obstruction/etiology , Ureteral Obstruction/surgery
13.
Klin Khir ; (4): 47-9, 2000.
Article in Russian | MEDLINE | ID: mdl-10857346

ABSTRACT

In 83.7% of patients with nephrolithiasis the morpho-functional disorders of urinary ways were disclosed. The complex of pathogenetically substantiated treatment of such patients was proposed. Together with performing of sparing removing of calculi the operative correction of hemo- and urodynamics with disorders local homeostasis restoration is performed using application of specific inhibitors of urolithogenesis, basing on hyperbaric oxygenation.


Subject(s)
Nephrocalcinosis/surgery , Humans , Nephrocalcinosis/etiology , Treatment Outcome , Urodynamics/physiology
15.
Cir Pediatr ; 10(1): 13-7, 1997 Jan.
Article in Spanish | MEDLINE | ID: mdl-9131957

ABSTRACT

Parathyroid surgery among pediatric population is an exceptional event. Sometimes, chronic renal failure cause independent and uncontrolled parathyroid overfunction; in this situation, a pediatric surgeon may be required. We report herein three kidney transplant patients who were diagnosed of tertiary hyperparathyroidism. Medical treatment didn't control the disease, so total parathyroidectomy with autotransplant in the forearm was indicated. The two patients who underwent surgery are free of the disease with a follow-up period of 6 and 26 months respectively. The other patient died a few days before the operation.


Subject(s)
Hyperparathyroidism/surgery , Adolescent , Child , Female , Follow-Up Studies , Humans , Hypercalcemia/etiology , Hyperparathyroidism/complications , Kidney/pathology , Kidney Transplantation , Male , Nephrocalcinosis/etiology , Nephrocalcinosis/pathology , Nephrocalcinosis/surgery
17.
Kidney Int ; 47(5): 1419-25, 1995 May.
Article in English | MEDLINE | ID: mdl-7637271

ABSTRACT

Very few patients with familial hypomagnesemia, hypercalciuria and nephrocalcinosis have been described. Information about clinical course, familial studies or evolution after renal transplantation is very scant. We have studied eight patients with this syndrome who belong to five different families. The mean age at diagnosis was 15 +/- 7 years (5 to 25 years). The primary clinical data were polyuria-polydipsia (8 cases), ocular abnormalities (5), recurrent urinary tract infections (5) and recurrent renal colics with stone passage (2). Bilateral nephrocalcinosis was observed in all cases. Every patient showed hypomagnesemia (1.1 +/- 0.2 mg/dl) with inappropriately high urinary magnesium (Mg) excretions (70 +/- 17 mg/day), Mg clearances (4.4 +/- 1.2 ml/m) and Mg fractional excretions (16.2 +/- 7.1%). Hypercalciuria was present in every case except in those with advanced renal insufficiency. Serum parathormone levels were abnormally high. Serum calcium (Ca), phosphorus and potassium, and urinary excretions of uric acid and oxalate were normal. Neither chronic oral Mg administration nor thiazide diuretics normalized serum Mg levels or urinary Ca excretions, respectively. Follow-up was 6 +/- 4.5 years. Renal function worsened in every case with six patients starting on chronic dialysis after 4.3 +/- 3.8 years. The progression rate of renal insufficiency correlated with the severity of nephrocalcinosis. Five patients have received a kidney graft, and their serum Mg and urinary Ca have always been within normal values after transplantation. Twenty-six members of four of the affected families were studied: none of them showed hypomagnesemia, renal insufficiency or nephrocalcinosis. However, eleven cases (42%) had hypercalciuria and four of them presented with recurrent renal stones. Two family members had medullary sponge kidneys. In conclusion, progression to renal insufficiency is common in this syndrome; oral Mg and thiazide diuretics are ineffective to correct abnormalities. After kidney graft, tubular handling of Mg and Ca was normal. A striking incidence (42%) of hypercalciuria was found in the familial study.


Subject(s)
Calcium/urine , Magnesium Deficiency/genetics , Nephrocalcinosis/genetics , Adolescent , Adult , Calcium/blood , Child , Child, Preschool , Disease Progression , Female , Follow-Up Studies , Food, Fortified , Humans , Kidney Transplantation , Magnesium Deficiency/blood , Magnesium Deficiency/diet therapy , Male , Nephrocalcinosis/complications , Nephrocalcinosis/surgery , Pedigree , Renal Insufficiency/etiology , Renal Insufficiency/surgery , Retrospective Studies , Syndrome
18.
Eur J Pediatr Surg ; 2(3): 150-1, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1498104

ABSTRACT

Between 1974 and 1990 in 16 children (5 boys and 11 girls) with a duplex kidney and bifid ureter surgery was indicated. The mean age of the 15 already operated patients was 7 years (0.3-12 years). 14 had uretero-ureteric reflux, 1 had a stenosis of the ureteric bifurcation, and 1 had a lower pole pelvi-ureteric junction obstruction. An interpyelic anastomosis was performed in 14 and a ureteroneocystostomy "en bloc" in 1. The follow-up was 3-10 years with a mean of 5 years. All 15 patients had normal uroradiological findings, and out of the 9 patients with longer follow-up (more than 3 years) 7 had a significantly diminished infection rate.


Subject(s)
Kidney/abnormalities , Nephrocalcinosis/surgery , Ureter/abnormalities , Urinary Tract Infections/surgery , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Male , Nephrocalcinosis/etiology , Urinary Tract Infections/etiology
19.
J Urol (Paris) ; 96(4): 189-92, 1990.
Article in French | MEDLINE | ID: mdl-2212716

ABSTRACT

Subcapsular nephrectomy has advantages over classical nephrectomy in such cases with the kidney adhered to adjacent structures. Actually, to the usual indications, as chronic renal infection and previous renal surgery, we add up the nephrectomy of transplanted kidney, that forms our main indications. In our review of medical literature we haven't found any references about subcapsular nephrectomy in pediatric age. We report 31 cases of subcapsular nephrectomy from a total number of 121 nephrectomies performed in children during the last 20 years. We analyse the indications, surgical management, postoperative course and latter complications of subcapsular nephrectomy.


Subject(s)
Kidney Diseases/surgery , Kidney Transplantation , Kidney/injuries , Nephrectomy/methods , Adolescent , Child , Female , Humans , Hydronephrosis/surgery , Male , Nephrocalcinosis/surgery , Postoperative Complications
20.
Arthritis Rheum ; 31(9): 1199-203, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3422018

ABSTRACT

We describe a 38-year-old man who developed livedo reticularis and peripheral gangrene after bilateral nephrectomy. Pathologic evaluation revealed extensive crystalline deposits within the walls of subcutaneous blood vessels. The diagnosis of primary hyperoxaluria was established. This case demonstrates that the vasculopathy of primary oxalosis can mimic systemic necrotizing vasculitis.


Subject(s)
Gangrene/etiology , Hyperoxaluria/complications , Vascular Diseases/etiology , Adult , Amputation, Surgical , Extremities/blood supply , Gangrene/pathology , Gangrene/surgery , Humans , Ischemia/etiology , Male , Nephrectomy , Nephrocalcinosis/etiology , Nephrocalcinosis/surgery , Postoperative Complications , Vascular Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...